Skip to content

Marginal Bone Level Around Dental Implants in Periodontitis Patients

Evaluation of Marginal Bone Level Around Dental Implants With Two Types of Surface Characteristics in Periodontitis Patients

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07608523
Acronym
(MBL)
Enrollment
40
Registered
2026-05-27
Start date
2023-04-30
Completion date
2026-04-30
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implants, Gingival Inflammation, Marginal Bone Loss, Periodontal Probing Depth, Periodontitis

Keywords

SLA implant, Plasma spraying implant, Peri-implant bone, Periodontitis patients, Implant surface, Probing Depth, Gingival Index

Brief summary

This study evaluates and compares marginal bone level changes around dental implants with two different surface characteristics in patients with a history of periodontitis. Participants will receive dental implants and will be followed up for one year to assess bone level changes around the implants.

Detailed description

Patients with treated periodontitis who require dental implants will be divided into two groups based on implant surface type. Marginal bone level will be assessed radiographically at baseline, then at 3 months,6 months, and 12 months after implant placement. The study aims to determine whether implant surface characteristics influence marginal bone loss in periodontitis-susceptible patients over a one-year follow-up period.

Interventions

DEVICESLA Dental Implant

Sandblasted large-grit corundum and acid-etched (SLA) surface dental implant

DEVICEPlasma Spraying Dental Implant

Plasma spraying surface treated dental implant

Sponsors

Faculty of Dental Medicine for Girls
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants will be divided into four groups based on implant surface type and periodontal status: Group I: 15 periodontitis patients receiving sandblasted large-grit corundum and acid-etched (SLA) surface implants. Group II: 15 periodontitis patients receiving plasma spraying surface treated implants. Group III: 5 periodontally healthy patients receiving sandblasted large-grit corundum and acid-etched (SLA) surface implants. Group IV: 5 periodontally healthy patients receiving plasma spraying surface treated implants. All groups will be followed up for 12 months to assess marginal bone level changes radiographically.

Eligibility

Sex/Gender
ALL
Age
35 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Age ranged from 35 to 55 years old, with a history of periodontitis * Presence of at least one edentulous space * Presence of adequate bone volume to place implants and achieves primary implant stability without the need for bone reconstructive approaches * Absence of systemic diseases

Exclusion criteria

* Presence of para-functional habits * Chronic smokers or former smokers * Pregnancy and lactation * Any patient who is not willing to follow our treatment protocol

Design outcomes

Primary

MeasureTime frameDescription
Marginal Bone LevelBaseline, 3 months, 6 months, and 12 months after implant placementRadiographic assessment of marginal bone level changes around dental implants measured in millimeters using Cone Beam Computed Tomography (CBCT)

Secondary

MeasureTime frameDescription
Probing DepthBaseline, 3 months, 6 months, and 12 monthsprobing depth measured in millimeters around implants
Gingival IndexBaseline, 3 months, 6 months, and 12 monthsThe gingival condition around the implants were evaluated using the Löe and Silness Gingival Index. A plastic periodontal probe were used to gently assess the gingival tissues at four surfaces per implant (mesial, buccal, distal, and lingual). Each surface was scored from 0 to 3 as follows: 0 = Normal gingiva 1. = Mild inflammation (slight change in color, slight edema, no bleeding on probing) 2. = Moderate inflammation (redness, edema, bleeding on probing) 3. = Severe inflammation (marked redness and edema, ulceration, spontaneous bleeding)

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATOROsama Sayed EL-Shall, Professor

Faculty of Dental Medicine for Girls, Al-Azhar University, Cairo, Egypt

STUDY_DIRECTORLobna Mohamed Abd-ELaziz, Associate Professor

Faculty of Dental Medicine for Girls, Al-Azhar University, Cairo, Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026